CCI
VRTX icon

Columbus Circle Investors’s Vertex Pharmaceuticals VRTX Stock Holding History

Columbus Circle Investors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-146,664
Closed -$26.9M – 185
2019
Q2 		$26.9M Sell
146,664
-50,646
-26% -$8.85M 0.72% 56
2019
Q1 		$36.3M Sell
197,310
-6,172
-3% -$1.14M 0.92% 44
2018
Q4 		$33.7M Sell
203,482
-5,290
-3% -$917K 0.96% 39
2018
Q3 		$40.2M Sell
208,772
-15,053
-7% -$2.68M 0.8% 42
2018
Q2 		$38M Sell
223,825
-132,564
-37% -$20.5M 0.79% 42
2018
Q1 		$58.1M Sell
356,389
-16,274
-4% -$2.66M 1.18% 17
2017
Q4 		$55.8M Sell
372,663
-79,982
-18% -$11.8M 1.06% 27
2017
Q3 		$68.8M Buy
452,645
+4,017
+0.9% +$605K 1.17% 21
2017
Q2 		$57.8M Buy
448,628
+391,454
+685% +$47.1M 0.96% 35
2017
Q1 		$6.25M Buy
57,174
+31,988
+127% +$2.82M 0.09% 179
2016
Q4 		$1.85M Sell
25,186
-51,013
-67% -$4.15M 0.02% 217
2016
Q3 		$6.64M Sell
76,199
-7,468
-9% -$706K 0.07% 195
2016
Q2 		$7.2M Buy
83,667
+49,127
+142% +$4.24M 0.07% 194
2016
Q1 		$2.75M Sell
34,540
-171,105
-83% -$15.5M 0.02% 217
2015
Q4 		$25.9M Buy
205,645
+24,013
+13% +$2.9M 0.21% 112
2015
Q3 		$18.9M Buy
+181,632
New +$23.3M 0.15% 130
2014
Q1 		– Sell
-63,838
Closed -$4.74M – 328
2013
Q4 		$4.74M Sell
63,838
-329,654
-84% -$23M 0.03% 249
2013
Q3 		$29.8M Sell
393,492
-135,087
-26% -$10.7M 0.21% 124
2013
Q2 		$42.3M Buy
+528,579
New +$38.9M 0.34% 83

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Columbus Circle Investors's VRTX Position: Q3 2019 in Review

Columbus Circle Investors sold out of Vertex Pharmaceuticals (VRTX) in Q3 2019, closing a stake of 146,664 shares — an estimated $26.9M sold.

Columbus Circle Investors first reported a position in VRTX in Q2 2013 and held it in 19 quarters. The position peaked at $68.8M in Q3 2017. 708 funds tracked by Wall St. Rank hold VRTX as of Q3 2019.

  • Columbus Circle Investors reported no remaining Vertex Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Columbus Circle Investors sold 146,664 Vertex Pharmaceuticals shares in Q3 2019, an estimated $26.9M.
  • Columbus Circle Investors first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 19 quarters.
  • Columbus Circle Investors's Vertex Pharmaceuticals position peaked at $68.8M in Q3 2017.
  • 708 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2019.

Based on Columbus Circle Investors's 13F filing for Q3 2019, filed 29 Oct 2019.